{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T03:49:31Z","timestamp":1727063371282},"reference-count":86,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ccep.2010.09.010","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T09:50:45Z","timestamp":1290592245000},"page":"587-598","source":"Crossref","is-referenced-by-count":4,"title":["Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"2","author":[{"given":"Christopher","family":"Critoph","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ccep.2010.09.010_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ccep.2010.09.010_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccep.2010.09.010_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1006\/jmcc.2001.1340","article-title":"The molecular genetic basis for hypertrophic cardiomyopathy","volume":"33","author":"Marian","year":"2001","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"17","key":"10.1016\/j.ccep.2010.09.010_bib4","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. EUROGENE heart failure project","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccep.2010.09.010_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0092-8674(01)00242-2","article-title":"The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms","volume":"104","author":"Seidman","year":"2001","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.ccep.2010.09.010_bib6","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1161\/01.CIR.0000072343.81530.75","article-title":"Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy","volume":"107","author":"Maron","year":"2003","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ccep.2010.09.010_bib7","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","article-title":"Task force on clinical expert consensus documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology","volume":"42","author":"Maron","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccep.2010.09.010_bib8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/hrt.2003.031161","article-title":"Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy","volume":"91","author":"Thaman","year":"2005","journal-title":"Heart"},{"issue":"25","key":"10.1016\/j.ccep.2010.09.010_bib9","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.jacc.2007.02.061","article-title":"Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype","volume":"49","author":"Kubo","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccep.2010.09.010_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1540-8167.2007.00965.x","article-title":"Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics","volume":"19","author":"Alcalai","year":"2008","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"22","key":"10.1016\/j.ccep.2010.09.010_bib11","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/eurheartj\/ehi438","article-title":"Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy","volume":"26","author":"Perkins","year":"2005","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ccep.2010.09.010_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yjmcc.2008.05.016","article-title":"Sex hormone receptor gene variation associated with phenotype in male hypertrophic cardiomyopathy patients","volume":"45","author":"Lind","year":"2008","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"12","key":"10.1016\/j.ccep.2010.09.010_bib13","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1253\/circj.71.1932","article-title":"A985G polymorphism of the endothelin-2 gene and atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"71","author":"Nagai","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.ccep.2010.09.010_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.genom.6.080604.162305","article-title":"Noonan syndrome and related disorders: genetics and pathogenesis","volume":"6","author":"Tartaglia","year":"2005","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"4","key":"10.1016\/j.ccep.2010.09.010_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archpedi.1968.02100020377005","article-title":"Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease","volume":"116","author":"Noonan","year":"1968","journal-title":"Am J Dis Child"},{"issue":"2","key":"10.1016\/j.ccep.2010.09.010_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/adc.67.2.178","article-title":"A\u00a0clinical study of Noonan syndrome","volume":"67","author":"Sharland","year":"1992","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.ccep.2010.09.010_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ccep.2010.09.010_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1939","article-title":"Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome","volume":"39","author":"Tartaglia","year":"2007","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ccep.2010.09.010_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1926","article-title":"Germline gain-of-function mutations in SOS1 cause Noonan syndrome","volume":"39","author":"Roberts","year":"2007","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.ccep.2010.09.010_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.ccep.2010.09.010_bib21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.ccep.2010.09.010_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng2078","article-title":"Germline gain-of-function mutations in RAF1 cause Noonan syndrome","volume":"39","author":"Razzaque","year":"2007","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.ccep.2010.09.010_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/341528","article-title":"Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene","volume":"71","author":"Digilio","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.ccep.2010.09.010_bib24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","article-title":"The heart in Anderson-Fabry disease and other lysosomal storage disorders","volume":"93","author":"Linhart","year":"2007","journal-title":"Heart"},{"issue":"6798","key":"10.1016\/j.ccep.2010.09.010_bib25","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ccep.2010.09.010_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.31.1.51","article-title":"Lysosomal glycogen storage disease with normal acid maltase","volume":"31","author":"Danon","year":"1981","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ccep.2010.09.010_bib27","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/WNL.58.12.1773","article-title":"Clinicopathological features of genetically confirmed Danon disease","volume":"58","author":"Sugie","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ccep.2010.09.010_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/CND.0b013e318176dbe4","article-title":"Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy","volume":"9","author":"Katzin","year":"2008","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"issue":"1","key":"10.1016\/j.ccep.2010.09.010_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2005-837543","article-title":"Enzyme replacement therapy in classical infantile Pompe disease: results of a ten-month follow-up study","volume":"36","author":"Klinge","year":"2005","journal-title":"Neuropediatrics"},{"issue":"11","key":"10.1016\/j.ccep.2010.09.010_bib30","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/hmg\/10.11.1215","article-title":"Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis","volume":"10","author":"Blair","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.ccep.2010.09.010_bib31","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2004.11.053","article-title":"Adenosine monophosphate-activated protein kinase disease mimics hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history","volume":"45","author":"Murphy","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccep.2010.09.010_bib32","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1542\/peds.2004-0718","article-title":"Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease","volume":"114","author":"Scaglia","year":"2004","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ccep.2010.09.010_bib33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0195-668X(02)00387-1","article-title":"Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings","volume":"24","author":"Holmgren","year":"2003","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ccep.2010.09.010_bib34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0887-8994(03)00004-3","article-title":"Friedreich\u2019s ataxia","volume":"28","author":"Alper","year":"2003","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.ccep.2010.09.010_bib35","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0735-1097(86)80159-0","article-title":"Cardiac involvement in Friedreich\u2019s ataxia: a clinical study of 75 patients","volume":"7","author":"Child","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2010.09.010_bib36","first-page":"423","article-title":"Progression of cardiopathology in Friedreich ataxia: clinico-instrumental study","volume":"35","author":"Casazza","year":"1990","journal-title":"Cardiologia"},{"issue":"6","key":"10.1016\/j.ccep.2010.09.010_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2559.1995.tb00267.x","article-title":"Hypertrophic cardiomyopathy\u2013pathology and pathogenesis","volume":"26","author":"Davies","year":"1995","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.ccep.2010.09.010_bib38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2559.2004.01835.x","article-title":"The pathology of hypertrophic cardiomyopathy","volume":"44","author":"Hughes","year":"2004","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.ccep.2010.09.010_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","article-title":"Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy","volume":"8","author":"Maron","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccep.2010.09.010_bib40","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/01.CIR.84.2.686","article-title":"Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy","volume":"84","author":"Counihan","year":"1991","journal-title":"Circulation"},{"issue":"9424","key":"10.1016\/j.ccep.2010.09.010_bib41","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(04)16358-7","article-title":"Hypertrophic cardiomyopathy","volume":"363","author":"Elliott","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ccep.2010.09.010_bib42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0002-9149(79)90388-6","article-title":"Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients","volume":"44","author":"Yamaguchi","year":"1979","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2010.09.010_bib43","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.CIR.80.5.1259","article-title":"Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients","volume":"80","author":"Fananapazir","year":"1989","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccep.2010.09.010_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/hrt.43.3.245","article-title":"Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways","volume":"43","author":"Krikler","year":"1980","journal-title":"Br Heart J"},{"issue":"7","key":"10.1016\/j.ccep.2010.09.010_bib45","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/0735-1097(95)00390-8","article-title":"Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients","volume":"26","author":"Klues","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccep.2010.09.010_bib46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9149(81)90068-0","article-title":"Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients","volume":"48","author":"Maron","year":"1981","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ccep.2010.09.010_bib47","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0735-1097(83)80269-1","article-title":"Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study","volume":"2","author":"Shapiro","year":"1983","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccep.2010.09.010_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0033-0620(85)90024-6","article-title":"Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy [a review]","volume":"28","author":"Wigle","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"issue":"21","key":"10.1016\/j.ccep.2010.09.010_bib49","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ccep.2010.09.010_bib50","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/hrt.2007.126003","article-title":"Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy","volume":"94","author":"Shah","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.ccep.2010.09.010_bib51","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/01.CIR.91.4.1189","article-title":"Papillary muscle displacement causes systolic anterior motion of the mitral valve; experimental validation and insights into the mechanism of subaortic obstruction","volume":"91","author":"Robert","year":"1995","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccep.2010.09.010_bib52","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.90.1.186","article-title":"Regional heterogeneity of function in hypertrophic cardiomyopathy","volume":"90","author":"Kramer","year":"1994","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ccep.2010.09.010_bib53","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/S0735-1097(02)02602-5","article-title":"Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy","volume":"40","author":"Choudhury","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ccep.2010.09.010_bib54","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0735-1097(03)00189-X","article-title":"Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance","volume":"41","author":"Moon","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ccep.2010.09.010_bib55","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O\u2019Hanlon","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccep.2010.09.010_bib56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/hrt.80.1.60","article-title":"Cardiopulmonary responses to exercise in patients with hypertrophic cardiomyopathy","volume":"80","author":"Jones","year":"1998","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ccep.2010.09.010_bib57","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0735-1097(00)00816-0","article-title":"Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes","volume":"36","author":"Sharma","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccep.2010.09.010_bib58","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/S0735-1097(99)00094-7","article-title":"Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy","volume":"33","author":"Olivotto","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ccep.2010.09.010_bib59","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1161\/01.CIR.96.9.2987","article-title":"Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy","volume":"96","author":"Sadoul","year":"1997","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccep.2010.09.010_bib60","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0735-1097(02)01950-2","article-title":"Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy","volume":"40","author":"Ciampi","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccep.2010.09.010_bib61","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2010.09.010_bib62","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients","volume":"42","author":"Monserrat","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccep.2010.09.010_bib63","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1540-8159.2007.00753.x","article-title":"Sustained ventricular tachycardia in apical hypertrophic cardiomyopathy, midcavitary obstruction, and apical aneurysm","volume":"30","author":"Sanghvi","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"issue":"21","key":"10.1016\/j.ccep.2010.09.010_bib64","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccep.2010.09.010_bib65","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0735-1097(10)80014-2","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study","volume":"15","author":"Robinson","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2010.09.010_bib66","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0735-1097(03)00855-6","article-title":"Clinical course of hypertrophic cardiomyopathy with survival to advanced age","volume":"42","author":"Maron","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ccep.2010.09.010_bib67","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/0002-9149(93)91117-Z","article-title":"Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history","volume":"72","author":"Maron","year":"1993","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ccep.2010.09.010_bib68","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.106.621185","article-title":"Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry","volume":"115","author":"Colan","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccep.2010.09.010_bib69","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.pcl.2004.04.017","article-title":"Hypertrophic cardiomyopathy in childhood","volume":"51","author":"Maron","year":"2004","journal-title":"Pediatr Clin North Am"},{"issue":"12","key":"10.1016\/j.ccep.2010.09.010_bib70","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM198903233201201","article-title":"Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population","volume":"320","author":"Spirito","year":"1989","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccep.2010.09.010_bib71","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.90.6.2743","article-title":"Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia","volume":"90","author":"Spirito","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2010.09.010_bib72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0002-9149(87)90998-2","article-title":"Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy","volume":"60","author":"Spirito","year":"1987","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ccep.2010.09.010_bib73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ccep.2010.09.010_bib74","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/01.CIR.99.16.2132","article-title":"Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis","volume":"99","author":"Spirito","year":"1999","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.ccep.2010.09.010_bib75","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1161\/01.CIR.99.22.2927","article-title":"Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY)","volume":"99","author":"Maron","year":"1999","journal-title":"Circulation"},{"issue":"9202","key":"10.1016\/j.ccep.2010.09.010_bib76","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)82005-X","article-title":"Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy","volume":"355","author":"Maron","year":"2000","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ccep.2010.09.010_bib77","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0003-4975(00)01314-X","article-title":"Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy","volume":"69","author":"Merrill","year":"2000","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.ccep.2010.09.010_bib78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1996.03540030033028","article-title":"Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles","volume":"276","author":"Maron","year":"1996","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ccep.2010.09.010_bib79","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0735-1097(99)00056-X","article-title":"Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy","volume":"33","author":"Elliott","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccep.2010.09.010_bib80","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0735-1097(93)90193-5","article-title":"Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy","volume":"22","author":"Dilsizian","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2010.09.010_bib81","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/hrt.2003.020529","article-title":"Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy","volume":"90","author":"Frenneaux","year":"2004","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.ccep.2010.09.010_bib82","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/europace\/euq261","article-title":"Heart rhythm UK Familial Sudden Cardiac Death Syndromes Statement Development Group. Heart rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes","volume":"12","author":"Garratt","year":"2010","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.ccep.2010.09.010_bib83","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1023\/A:1021161114347","article-title":"Role of invasive EP testing in the evaluation and management of hypertrophic cardiomyopathy","volume":"6","author":"Behr","year":"2002","journal-title":"Card Electrophysiol Rev"},{"issue":"13","key":"10.1016\/j.ccep.2010.09.010_bib84","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/eurheartj\/ehn111","article-title":"Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy","volume":"29","author":"Saumarez","year":"2008","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ccep.2010.09.010_bib85","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0735-1097(02)02495-6","article-title":"Risk associated with pregnancy in hypertrophic cardiomyopathy","volume":"40","author":"Autore","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccep.2010.09.010_bib86","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/heart.89.7.752","article-title":"Pregnancy related complications in women with hypertrophic cardiomyopathy","volume":"89","author":"Thaman","year":"2003","journal-title":"Heart"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918210001188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918210001188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T12:53:14Z","timestamp":1711975994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918210001188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1877918210001188"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2010.09.010","relation":{},"ISSN":["1877-9182"],"issn-type":[{"value":"1877-9182","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}